Lentigen and Dharmacon Pen shRNA Development Deal

Lentigen and Dharmacon Pen shRNA Development Deal
August 30, 2006
GenomeWeb
NEW YORK (GenomeWeb News) ? Lentigen and Dharmacon today said they plan to develop and manufacture lentiviral expression reagents to deliver short hairpin RNA expression vectors into cells using RNA interference-mediated gene silencing.

As part of the alliance Dharmacon will design reagents combined with Lentigen's high-titer LentiMax vector system to develop the lentiviral particles. Terms of the deal call for Lentigen to manufacture and Dharmacon to sell the resulting products.

Financial details were not disclosed.
Comments: 0
Votes:11